# Hamilton Lane INC: overview

HLNE · Nasdaq · CIK 1433642 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/hlne.md) · [Financials](/companies/hlne/financials.md) · [Filings](/companies/hlne/filings.md) · [Insiders](/companies/hlne/insiders.md)

Latest reported revenue: [$275.3m](/filings/0001433642-26-000042.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001433642-26-000042).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [150](/filings/0001433642-25-000117.md) | [168](/filings/0001433642-26-000007.md) | [198 d](/filings/0001433642-26-000019.md) | [176](/filings/0001433642-26-000042.md) | [191](/filings/0001433642-25-000117.md) | [199](/filings/0001433642-26-000007.md) | [194 d](/filings/0001433642-26-000019.md) | [275](/filings/0001433642-26-000042.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [36.7%](/filings/0001433642-25-000117.md) | [31.5%](/filings/0001433642-26-000007.md) | [25.5% d](/filings/0001433642-26-000019.md) | [30.5%](/filings/0001433642-26-000042.md) | [37.1%](/filings/0001433642-25-000117.md) | [29.4%](/filings/0001433642-26-000007.md) | [34.2% d](/filings/0001433642-26-000019.md) | [29.2%](/filings/0001433642-26-000042.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [116 d](/filings/0001433642-25-000117.md) | [58.8 d](/filings/0001433642-26-000007.md) | [35.8 d](/filings/0001433642-26-000019.md) | [128](/filings/0001433642-26-000042.md) | [118 d](/filings/0001433642-25-000117.md) | [72.4 d](/filings/0001433642-26-000007.md) | [101 d](/filings/0001433642-26-000019.md) | [75.3](/filings/0001433642-26-000042.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [368](/filings/0001433642-24-000064.md) | [529](/filings/0001433642-25-000052.md) | [554](/filings/0001433642-26-000019.md) | [713](/filings/0001433642-26-000019.md) | [759](/filings/0001433642-26-000019.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [39.7%](/filings/0001433642-24-000064.md) | [20.6%](/filings/0001433642-25-000052.md) | [25.4%](/filings/0001433642-26-000019.md) | [30.5%](/filings/0001433642-26-000019.md) | [32.8%](/filings/0001433642-26-000019.md) |
| Diluted EPS | $ per share | [3.98](/filings/0001433642-22-000027.md) | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [161](/filings/0001433642-24-000064.md) | [222](/filings/0001433642-25-000052.md) | [110](/filings/0001433642-26-000019.md) | [289](/filings/0001433642-26-000019.md) | [419](/filings/0001433642-26-000019.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hlne/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $337.5m | 4,281,385 |  | Added +205,443 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $240.7m | 3,053,076 |  | Reduced −362,074 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $141.6m | 1,796,500 |  | Reduced −28,968 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $141.4m | 1,794,120 |  | Added +9,867 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $107.7m | 1,355,756 |  | Added +36,635 |
| [LOS ANGELES CAPITAL MANAGEMENT LLC](/funds/1177206.md) | 2026-06-30 | $95.8m | 1,215,166 |  | Added +536,675 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $94.8m | 1,203,158 |  | Added +1,178,193 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $90.8m | 1,151,560 |  | Reduced −600,036 |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $90.0m | 905,660 |  | Not compared |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $82.7m | 1,048,417 |  | Reduced −1,609 |

## Recent filings

[All 646 filings](/companies/hlne/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 10:59 ET | [8-K](/filings/0001433642-26-000048.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001433642-26-000048 |
| 2026-09-10 | 20:48 ET | [8-K](/filings/0001433642-26-000045.md) | 5.07 Shareholder vote results | 0001433642-26-000045 |
| 2026-08-04 | 20:14 ET | [10-Q](/filings/0001433642-26-000042.md) | Quarterly report, period 2026-06-30 | 0001433642-26-000042 |
| 2026-08-04 | 10:59 ET | [8-K](/filings/0001433642-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001433642-26-000039 |
| 2026-07-23 | 20:23 ET | [DEF 14A](/filings/0001433642-26-000034.md) | Proxy statement, period 2026-03-31 | 0001433642-26-000034 |
| 2026-05-29 | 22:07 ET | [SCHEDULE 13D/A](/filings/0001273303-26-000004.md) | Ownership report, active investor, amended | 0001273303-26-000004 |
| 2026-05-21 | 20:30 ET | [10-K](/filings/0001433642-26-000019.md) | Annual report, period 2026-03-31 | 0001433642-26-000019 |
| 2026-05-21 | 11:00 ET | [8-K](/filings/0001433642-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001433642-26-000016 |
| 2026-02-20 | 21:15 ET | [8-K](/filings/0001433642-26-000009.md) | 8.01 Other events | 0001433642-26-000009 |
| 2026-02-03 | 21:18 ET | [10-Q](/filings/0001433642-26-000007.md) | Quarterly report, period 2025-12-31 | 0001433642-26-000007 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001433642-26-000019.md), filed May 21, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ec9e33e0-9458-4427-8e12-d240acf125d9)

## About the filer

- CIK: 1433642
- Tickers: HLNE
- Exchange: Nasdaq
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.